StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Global Corporate Wellness market $53 Billion

<< Previous

Bullboard Posts

Next >>

Comment by Jonnyboy85on Mar 03, 2023 3:09pm

92 Views

Post# 35318296

RE:RE:RE:Global Corporate Wellness market $53 Billion

LithLover wrote: Hard to say but it's strange. I've used marketing companies to do SEO or social media posts. Usually the standard is 1-3 a week. This is very unusual to see 3 in a day or this many in a week.

agreed. Especially when you add the large structured accumulation recently, it lends to the idea that there is something meaty brewing

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario